Millennium Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60,476
Closed -$183K 6392
2024
Q4
$183K Sell
60,476
-98,576
-62% -$277K ﹤0.01% 5334
2024
Q3
$402K Sell
159,052
-245,526
-61% -$873K ﹤0.01% 4999
2024
Q2
$1.9M Buy
+404,578
New +$2.13M ﹤0.01% 3580
2023
Q4
Sell
-34,530
Closed -$276K 6527
2023
Q3
$276K Buy
+34,530
New +$321K ﹤0.01% 4975
2023
Q2
Sell
-104,366
Closed -$1.11M 6677
2023
Q1
$1.11M Buy
104,366
+50,230
+93% +$554K ﹤0.01% 3992
2022
Q4
$623K Buy
+54,136
New +$485K ﹤0.01% 4568
2022
Q3
Sell
-38,263
Closed -$272K 7491
2022
Q2
$272K Buy
+38,263
New +$318K ﹤0.01% 5446
2021
Q3
Sell
-61,078
Closed -$984K 7247
2021
Q2
$984K Buy
61,078
+43,237
+242% +$593K ﹤0.01% 4682
2021
Q1
$266K Buy
+17,841
New +$269K ﹤0.01% 5300
2020
Q3
Sell
-43,359
Closed -$562K 4816
2020
Q2
$562K Sell
43,359
-1,812
-4% -$23.8K ﹤0.01% 3335
2020
Q1
$353K Sell
45,171
-9,252
-17% -$125K ﹤0.01% 3082
2019
Q4
$705K Buy
+54,423
New +$666K ﹤0.01% 3177

Other funds holding TELA

Millennium Management's TELA Position: Q1 2025 in Review

Millennium Management sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 60,476 shares — an estimated $183K sold.

Millennium Management first reported a position in TELA in Q4 2019 and held it in 12 quarters. The position peaked at $1.9M in Q2 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

  • Millennium Management reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 60,476 TELA Bio shares in Q1 2025, an estimated $183K.
  • Millennium Management first reported a position in TELA Bio in Q4 2019 and held it in 12 quarters.
  • Millennium Management's TELA Bio position peaked at $1.9M in Q2 2024.
  • 50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.